Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
Chokri Ben Lamine, Adult Hematology and Stem Cell Transplantation Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on, recently shared on X:
“PTT Prolongation — Causes and Approach for Hema Fellows
Causes
- Factor deficiencies: VIII, IX, XI, XII
- Combined defects: Hemophilia A/B, vWD (type 2N), combined factor deficiencies
- Anticoagulants: UFH, argatroban, dabigatran
- Inhibitors: Lupus anticoagulant, acquired FVIII inhibitor
- Consumptive: DIC, massive transfusion
- Contact pathway defects: prekallikrein, HMW kininogen deficiency (no bleeding)
- Liver disease: decreased synthesis of multiple factors
Approach
- Check clinical context — bleeding vs thrombosis
- Repeat PTT — exclude lab error
- Mixing study:
- Corrects → factor deficiency → assay factors VIII, IX, XI, XII
- No correction → inhibitor → lupus anticoagulant or factor inhibitor workup
- If on anticoagulant — check drug level / anti-Xa / TT
- If prolonged with normal PT — think intrinsic pathway
- If prolonged PT and PTT — consider liver disease, DIC, multiple deficiencies
Written Exam Pearl
Isolated prolonged PTT + no bleeding → think lupus anticoagulant or contact factor deficiency.
OSCE Practical Tip
•Scenario: Post-op patient with thrombosis, PTT 65s, normal PT
Don’t rush to transfuse FFP — think lupus anticoagulant → do mixing study + DRVVT.
•Always ask about heparin flushes from lines before labs.
References:
1.Kitchens CS et al. Consultative Hemostasis and Thrombosis, 5th ed, 2023.
2.ISTH Guidelines 2024 — Lupus Anticoagulant Testing.
3.ASH Education Program 2022 — Approach to Abnormal Coagulation Tests.”
Stay updated on the latest with Hemostasis Today.
-
Oct 9, 2026, 23:46Samuel Misiani Mbunya: Advancing Sickle Cell Care Through Collaboration at the 21st ASCAT Conference
-
Oct 9, 2026, 23:42Hadeel Swed: My First First-Author Publication in Thrombosis Research
-
Oct 9, 2026, 23:38Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference